Given that almost 40% of patients with diabetes are already hypertensive at the time of their diabetes diagnosis, 1 there has been considerable interest in a potential link between prediabetic states and the development of hypertension (HTN). This association has important public health implications given the known increase in both microvascular and macrovascular diabetic complications among hypertensive individuals. 2 However, any relationship between dysglycemia and incident HTN must properly consider the influence of body weight given the inherent associations between body mass index (BMI), glucose metabolism, and blood pressure.
Given that almost 40% of patients with diabetes are already hypertensive at the time of their diabetes diagnosis, 1 there has been considerable interest in a potential link between prediabetic states and the development of hypertension (HTN). This association has important public health implications given the known increase in both microvascular and macrovascular diabetic complications among hypertensive individuals. 2 However, any relationship between dysglycemia and incident HTN must properly consider the influence of body weight given the inherent associations between body mass index (BMI), glucose metabolism, and blood pressure.
Studies from basic and translational science support a relationship between both obesity, insulin resistance, and arterial HTN 3, 4 with endothelial dysfunction being a potential intermediary in these relationships. [4] [5] [6] [7] The association between obesity and HTN has been borne out in multiple large epidemiological studies. [8] [9] [10] However, despite interest in the connection between prediabetic states and the development of HTN, data from large prospective cohorts are sparse. Chronic hyperglycemia as measured by hemoglobin A 1c (HbA 1c ) levels may reflect either a defect in pancreatic β-cell function and/or insulin resistance, both of which are known to occur in prediabetic states. 11 Therefore, the present study prospectively evaluated whether HbA 1c is associated with incident HTN in the Women's Health Study (WHS), and considered the role of body weight in any such association.
Methods
Study population. The present study analyzed data from the WHS, a randomized clinical trial of low-dose aspirin and Background although basic research has implicated abnormal glucose metabolism in the pathogenesis of hypertension (hTN), epidemiologic studies are limited.
We assessed whether baseline hemoglobin a 1c (hba 1c ) was prospectively associated with hTN in the Women's health Study (WhS). We analyzed 19,858 women initially free of hTN, diabetes, and cardiovascular disease (cVD) with baseline blood samples. We considered quintiles and clinical cutpoints of hba 1c for the risk of hTN, defined as either a new physician diagnosis, the initiation of antihypertensive treatment, or systolic blood pressure (SBP) ≥140 or diastolic blood pressure (DBP) ≥90 mm hg.
results
During a median follow-up of 11.6 years, 9,408 (47.5%) women developed hTN. In models adjusted for traditional cardiovascular risk factors, the hazard ratios (hrs) from the lowest (<4.8%, referent) to the highest (≥5.2%) quintile of hba 1c were 1.0 (referent), 0.99, 1.06, 1.08, and 1.21 (P, linear trend <0.0001). however, additional adjustment for body mass index (BmI) eliminated the relation (extreme quintile comparison hr 1.04; P, linear trend 0.10). For clinical cutpoints, a similar pattern emerged although a positive association between hba 1c and hTN remained in the highest category.
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Hemoglobin A 1c and Risk of Hypertension vitamin E in the primary prevention of cardiovascular disease (CVD) and cancer. A detailed description of WHS has been previously published. 12 Between 1992 and 1995, a total of 39,876 US female health professionals aged 45 years and older without prior diagnosed CVD or cancer (except nonmelanoma skin cancer) were enrolled and randomized into the study. Follow-up during the trial and during the observational period after the completion of the trial in 2004 has been excellent (>95%). 12 Of these women, 11,805 were excluded due to prerandomization diagnosed HTN (n = 10,318), missing information on HTN status at baseline (n = 597), missing information on BMI (n = 820), and prerandomization self-reported diabetes (n = 1,160). Among the remaining 28,071 women, 19,955 (71%) had provided baseline blood specimens. Of the samples received from the group, we were able to measure HbA 1c in 19,858 subjects. Of these subjects, 56 subjects had a HbA 1c ≥6.5% and were therefore considered to have baseline diabetes and excluded leaving a final sample size of 19,802.
Women provided self-reports on mailed questionnaires of baseline risk factors including age, smoking, parental history of myocardial infarction before age 60 years, vigorous exercise, alcohol use, blood pressure, history of high cholesterol (treatment, diagnosis, or total cholesterol ≥240 mg/dl), diabetes, and postmenopausal hormone use. BMI, in kg/m 2 , was calculated from height and weight. At baseline, participants completed a 131-item validated Semiquantitative Food Frequency Questionnaire. Details of the Semiquantitative Food Frequency Questionnaire and its use in the WHS have been previously reported. [13] [14] [15] On the baseline questionnaire in WHS, we also collected information on self-reported systolic and diastolic blood pressure (DBP), treatment for high blood pressure (never, past, current), and history of a diagnosis of HTN (no, yes). Baseline HTN was defined as past or current antihypertensive treatment, a prior HTN diagnosis, systolic blood pressure (SBP) ≥140 mm Hg, or DBP ≥90 mm Hg at study entry. A previous validation of self-reported blood pressure in female nurses found that medical record review confirmed 100% of cases where women reported a blood pressure ≥140/90 and 91% of cases where women reported a blood pressure ≥160/95. 16 Another study demonstrated a high correlation between a single measure of self-reported blood pressure in health professionals and measured SBP (r = 0.72) and DBP (r = 0.60). 17 All participants gave written informed consent, and the study protocol was approved by the institutional review board at Brigham and Women's Hospital, Boston, MA.
Outcome ascertainment. To be considered an incident case of HTN during follow-up, participants must meet at least one of the following four criteria: (i) self-report of a new physician diagnosis on follow-up questionnaires at years 1, 3, or annually thereafter; (ii) self-report of newly initiated antihypertensive treatment at years 1, 3, or 4; (iii) self-reported SBP ≥140 mm Hg; or (iv) self-reported DBP ≥90 mm Hg. We have previously validated self-reported HTN in WHS. 18 Women provided the month and year of physician-diagnosed HTN, and if this information was not provided or the diagnosis of HTN was made by another method, then the month and year of diagnosis was assigned a random date between the current and previous questionnaire. If women developed CVD before HTN, they were censored at that point as their CVD diagnosis would likely influence subsequent blood pressure levels during follow-up. 19 Statistical analysis. Baseline characteristics were compared across quintiles of HbA 1c . For each quintile of HbA 1c , we computed the incidence rate of HTN by dividing the number of cases by their corresponding person-time. We used Cox proportional hazards models to compute multivariable-adjusted hazard ratios (HRs) with corresponding 95% confidence intervals. Assumptions for the proportional hazards models were tested by including main effects and product terms of covariates and time factor. These assumptions were met as all P values were >0.05. The initial model adjusted only for age (continuous). The multivariable model additionally controlled for smoking (never, former, <15 cigarettes per day, ≥15 cigarettes/day), alcohol use (rarely/never, 1-3 drinks/month, 1-6 drinks/week, and ≥1 drink/day), physical activity (rarely/ never, <1 time/week, 1-3 times/week, or ≥4 times/week), hormone replacement therapy (never, past, current), history of elevated cholesterol ≥240 mg/dl or use of cholesterol lowering medication, and family history of myocardial infarction before age 60. We then ran a final multivariable model adding BMI as a continuous variable, given the known importance of body weight in the relationship between HbA 1c and HTN. Tests of linear trends were computed using median values within each quintile. We then assessed the potential confounding effects of adding baseline SBP, DBP, dietary factors, and C-reactive protein into the model. We performed a separate analysis to look at the impact of a diagnosis of prevalent diabetes on the risk of HTN. Women with self-reported diabetes at study entry or HbA 1c ≥6.5 were included as a separate category and their risk was compared to those subjects without diabetes in the lowest quintile of HbA 1c . We also re-examined the relationship between HbA 1c and the risk of HTN using the clinical cutpoints of <5, 5-5.5, 5.5-6, and >6%. Table 2) . Additional adjustment for dietary factors, C-reactive protein, baseline SBP, and DBP did not significantly alter these findings.
In our analysis that included subjects with baseline prevalent diabetes (defined by self-report or a baseline HbA 1c ≥6.5%) as a separate category, the HR for incident HTN among subjects with diabetes was 1.55 (1.36-1.77) in the multivariable plus 1.08, 1.90) ). However, as opposed to the results with HbA 1c quintiles, the linear trend across categories in this latter BMI-adjusted persisted (P for trend = 0.02) with this finding driven by subjects having HbA 1c values >5.5%.
In analyses stratified by World Health Organization BMI category, the risk of HTN was similar in subjects regardless of BMI category in the multivariable plus BMI-adjusted models (P for interaction, 0.87) (Figure 1) . In analyses stratified by baseline SBP, the risk of HTN was significantly different in subjects with baseline SBP <120 mm Hg compared with ≥120 mm Hg in the multivariable plus BMI-adjusted model (P for interaction, 0.0004). For each HbA 1c quintile, HRs for incident HTN were higher in subjects with baseline SBP <120 mm Hg (Figure 1) although there was no significant linear trend across quartiles of HbA 1c .
discussion
In this large, long-term prospective cohort study, we found a positive association between increasing HbA 1c quintile and increased risk of developing HTN in both age-adjusted models and models controlling for the majority of traditional HTN and coronary risk factors. However, after addition of BMI to our multivariable models, the relation between HbA 1c and HTN was no longer statistically significant. In contrast, using clinical cutpoints of HbA 1c , a significantly increased risk of HTN was present in nondiabetics with HbA 1c >6% even in multivariable models which included BMI. These findings emphasize both the powerful influence of BMI on the development of HTN as well as the strong relationship between adiposity and metabolic factors, including HbA 1c .
Despite evidence in the basic and translational sciences of an association between either glycemia or insulin resistance and HTN, the corresponding epidemiological studies have been comparatively limited and provide conflicting results. A series of studies have looked at the association between glycemia and the association with HTN. Overall, these studies tended to find an association between either fasting or postload glycemia and incident HTN although the findings somewhat differed by gender. [20] [21] [22] Given the interest in a link between insulin resistance, as opposed to purely glycemia, and HTN, other studies have also examined markers of insulin resistance and sensitivity and their relationship with HTN. The Paris Prospective Study examined the association between insulin levels and incident HTN. 22 After adjustment for BMI, insulin levels were only associated with HTN in the presence of a family history of HTN. In contrast, both a cross-sectional study in Iran using the homeostatic model of insulin resistance and a prospective analysis in the Insulin Resistance Atherosclerosis Study examining insulin sensitivity, 23, 24 suggest an association between insulin resistance and HTN. A slightly different cross-sectional analysis by the Framingham Heart Study using echocardiographic markers of left ventricular mass, as opposed to clinical HTN, as the outcome did show a significant association between glucose tolerance and left ventricular mass. Insulin resistance, as measured by the homeostasis model, was only associated with left ventricular mass in women, and this relationship lost statistical significance after adjustment for BMI.
To our knowledge, only cross-sectional epidemiological studies have specifically focused on the relationship between HbA 1c and HTN. Similar to the studies of glycemia, the results of all of these studies highlight the importance of BMI in this relationship and present conflicting results in terms of gender. In a cross-sectional analysis of the Framingham Heart Study, 25 there was a positive association between HbA 1c and HTN. However, this was a univariate analyses and therefore did not adjust for obesity. A cross-sectional study of 746 men and 595 women in Taiwan examined the relationship between HbA 1c as a continuous variable and SBP. In men, an association between HbA 1c and SBP persisted after adjustment for both age and BMI, but the regression coefficient diminished from 1.57 to 1.03. 26 Importantly, this study did not exclude subjects with diabetes although only 2% of the population had an HbA 1c above 7%. Finally, a cross-sectional analysis of 1,846 nondiabetic subjects from the EPIC-Postdam cohort study 27 found a univariate association between increasing HbA 1c and HTN, but this relationship disappeared after adjustment for age and BMI.
Both the previous cross-sectional data and our prospective analysis are largely consistent, all supporting the existence of a relationship between HbA 1c and HTN that is substantially diminished or abolished with additional adjustment for BMI, emphasizing the essential role of body weight in the relationship between glucose metabolism and HTN. Our study also emphasizes the significant risk of HTN among nondiabetic subjects with HbA 1c above 6.0% in which the relationship between HbA 1c and incident HTN remains significant despite adjustment for BMI.
Our findings support the presence of multifaceted connections between prediabetic states and incident HTN, and emphasize the need for further understanding of potential pathophysiologic links between glycemia, insulin resistance, measures of adiposity, and HTN. These are the same risk factors that define the metabolic syndrome, which has been associated with an increased risk of CVD. 28 Epidemiological studies have established that increasing BMI increases the risk of diabetes, and presumably insulin resistance, 29 and there is strong scientific consensus that overweight and obesity are antecedents to the development of insulin resistance among other metabolic abnormalities. However, the effect of insulin resistance on adipocyte pathophysiology and clinical fat deposition remains an area of active investigation. Experimental evidence has demonstrated that obese individuals have a higher free-fatty acid flux,
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Hemoglobin A 1c and Risk of Hypertension and these circulating free-fatty acids have been shown to cause peripheral insulin resistance. However, this relationship may not be unidirectional as these circulating free-fatty acids associated with obesity not only cause insulin resistance, but are also deposited into nonadipose tissues, including both muscle and liver. 30, 31 Hepatocytes, when activated by factors including fat deposition, are known to have increased secretion of both inflammatory cytokines and angiotensin II 32,33 which may contribute to the development of HTN. These findings emphasize the complex relationship between BMI and glucose metabolism and suggest that fat deposition may not only be a confounder of the relationship between HbA 1c and HTN, but may also be a causal intermediate. Therefore, it may be difficult to completely untangle the effects of insulin resistance and BMI in terms of their influence on the development of HTN.
The major strengths of our study include the large number of cases of incident HTN accrued over a long period of follow-up, allowing for sufficient statistical power to detect more modest effects. In addition, the available data on the important confounders strengthened the multivariate analysis. Our study does have some important limitations. The WHS population is confined to middle-aged and older women, limiting the generalizability of our findings to men and to younger women. Furthermore, both HbA 1c and lifestyle factors were measured at baseline, and our study does not take into account changes during follow-up. Misclassification bias is possible given the self-reporting of the outcome. However, HTN has previously been validated in the WHS with good accuracy. 18 Another possible limitation is our focus on HbA 1c , which is not a direct measure of insulin resistance. However, the use of the HOMA IR is not currently used in clinical practice due to the lack of standardization in the insulin assay across laboratories 34, 35 whereas HbA 1c is now standardized and widely available.
In conclusion, our findings suggest that increasing levels of HbA 1c , even within the normal range of HbA 1c <6.5%, are associated with an increasing risk of incident HTN among nondiabetic women prior to, but not after adjustment for BMI. Our findings highlight the complex and important interconnections among metabolic factors, including HbA 1c , body weight, and HTN, although the specific mechanisms underlying these likely links are still being elucidated. Additional research is needed to better understand the contributions of both adiposity and dysglycemia to the development of HTN in this setting.
